Charles Crain is the Senior Manager of Tax & Financial Services Policy at the Biotechnology Industry Organization (BIO). BIO represents more than 1,100 biotechnology companies, academic institutions, state biotechnology centers, and related organizations in all 50 states.
As the primary staffer for financial services issues on BIO’s Emerging Companies Section policy team, Charles’s portfolio includes capital markets, securities, accounting, and tax policies that impact BIO’s member companies. His particular areas of focus include policy development and advocacy for the Jumpstart Our Business Startups (JOBS) Act, including the implementation thereof, legislation to enhance capital markets access for emerging companies, market structure reform, decimalization and tick size, and small company auditing standards. He has also worked on issues related to the R&D tax credit and the tax treatment of net operating losses (NOLs). Charles serves as BIO’s representative to the Equity Capital Formation Task Force and the SEC Government-Business Forum on Small Business Capital Formation.
Prior to joining BIO, Charles worked on Capitol Hill for Congressman Paul Hodes and Senator Debbie Stabenow. Charles holds a Bachelor’s degree in political science from Mercer University and a Master’s in legislative affairs from The George Washington University.
News